Insider Transaction Report for Autolus Therapeutics plc

Michael Bonney, a director at Autolus Therapeutics plc, reported a transaction on June 29, 2026. He acquired 31,667 Restricted Share Units (RSUs), which represent a contingent right to receive one American Depositary Share (ADS) per unit. These RSUs are set to vest on June 29, 2027. Additionally, Bonney acquired 47,500 share options, giving him the right to buy ADSs. These options vest in twelve equal monthly installments starting July 29, 2026, with an exercise price of $1.61 per share. The options are exercisable until June 29, 2036. All transactions were marked as direct ownership.